MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2024-25)
- Udyam number
- UDYAM-TN-02-0003755
Sunberg Life Sciences Private Limited - pharma in Chennai, Tamil Nadu, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹24.43 Cr
▲ 92% YoY
Net loss · FY 2025
₹11.28 Lakh
Net margin -0.5%
EBITDA · FY 2025
₹3.46 Cr
EBITDA margin 14.2%
Authorised capital
₹9.5 Cr
Registered with MCA
Paid-up capital
₹9.5 Cr
Issued & subscribed
Open charges
₹36.52 Cr
Satisfied ₹4.57 Cr
Company age
11 yrs
Est. 2015
Employees · EPFO
51
Provident fund records
About Sunberg Life Sciences Private Limited
Data last updated:
Sunberg Life Sciences Private Limited is a private limited company based in Chennai, Tamil Nadu, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 03 February 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U51397TN2015PTC099067. Its GSTIN is 33AAVCS4160P1ZM (Tamil Nadu). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹9.5 Cr and a paid-up capital of ₹9.5 Cr. It is led by directors including Sivasamy Manohar and Alagappan.
Its last annual general meeting (AGM) was held on 27 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at New No. 15 Gopalakrishna Road T. Nagar, Chennai, Tamil Nadu, India – 600017.
As per the financials filed for FY 2025, the company reported a revenue of ₹24.43 Cr, a growth of 92% compared to the previous year. For the same year it recorded a net loss of ₹11.28 Lakh (net margin -0.5%) and EBITDA of ₹3.46 Cr (EBITDA margin 14.2%). Revenue has grown at a compounded annual rate (CAGR) of 42% over three years and 67% over five years.
The company has about 51 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Sunberg. As per MCA filings, the company has open charges of ₹36.52 Cr and satisfied charges of ₹4.57 Cr on record. The company has 3 deals on record (2 funding rounds, 1 rights issue), with disclosed funding of ₹7.5 Cr; the latest was in February 2020. Its 7 peer companies in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 4 larger and 3 smaller; the largest is Pharlink Labs Private Limited with revenue of ₹24.56 Cr.
Sunberg Life Sciences Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-TN-02-0003755). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website sun-berg.com.
Company details
CIN U51397TN2015PTC099067
Registration Number 099067
Incorporation Date 03 February 2015
ROC Chennai
Listing Status Unlisted
Company Status Active
Date of Last AGM 27 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-TN-02-0003755
Recognitions & Rankings of Sunberg Life Sciences
Contact details
Sunberg Life Sciences Private Limited's registered office is in Chennai, Tamil Nadu. Its website is sun-berg.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressNew No. 15 Gopalakrishna Road T. Nagar, Chennai, Tamil Nadu, India – 600017
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Sunberg Life Sciences Private Limited, buy the company report.
Comprehensive company report
Sunberg Life Sciences Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Sunberg Life Sciences operates one associated brand: SUNBERG. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Probiotics manufacturing and pharmaceutical services in India. | sun-berg.com |
Business activity
The main business activity of Sunberg Life Sciences is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Sunberg Life Sciences Private Limited, buy the company report.
Financials of Sunberg Life Sciences Private Limited
FY 2024 filings availableSunberg Life Sciences Private Limited reported revenue of ₹24.43 Cr (up 92% YoY) for FY 2025.
Revenue · FY 2025
₹24.43 Cr ▲ 92%
Net loss · FY 2025
₹11.28 Lakh margin -0.5%
EBITDA · FY 2025
₹3.46 Cr margin 14.2%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 92%
3 years · compounded
▲ 42%
5 years · compounded
▲ 67%
EBITDA CAGR growth
3 years · compounded
▲ 176%
5 years · compounded
▲ 78%
Revenue has grown at a compounded annual rate (CAGR) of 67% over five years, including 92% growth in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹3.46 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹11.28 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 14.2% | ||||
| Net Profit Margin | -0.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Sunberg Life Sciences Private Limited, buy the company report.
Board of directors of Sunberg Life Sciences Private Limited
Sunberg Life Sciences has 6 current directors and 8 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sivasamy Manohar Also directs: Pulmocare Lifesciences India Private Limited, Anphar Organics Private Limited., Maral Health Care Private Limited and 3 more | Director | 03 Feb 2015 | 11 Years 8 Months | Current |
| Alagappan Also directs: Anphar Organics Private Limited., Maral Health Care Private Limited, Madras Pharmaceuticals Private Limited and 2 more | Director | 17 Mar 2025 | 1 Years 7 Months | Current |
| Sulaiman Abdulhai Mohammed Also directs: Pulmocare Lifesciences India Private Limited, Anphar Organics Private Limited., Maral Health Care Private Limited and 5 more | Director | 04 Oct 2016 | 10 Years 0 Months | Current |
| Nagappan Kannappan Also directs: Anphar Organics Private Limited., Maral Health Care Private Limited, Madras Pharmaceuticals Private Limited and 2 more | Director | 03 Feb 2015 | 11 Years 8 Months | Current |
| Ogra Selvanathan Kumaran | Director | 09 Oct 2019 | 7 Years 0 Months | Current |
| Vijay Balakumar | Director | 12 Sep 2016 | 10 Years 1 Months | Current |
Peer comparison
Sunberg Life Sciences Private Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Pharlink Labs Private Limited | ₹24.56 Cr (FY 2024) | 111.0% | Chennai, Tamil Nadu, India | |||
| Remidex Pharma Private Limited | ₹24.56 Cr (FY 2025) | -22.0% | Bengaluru, Karnataka, India | |||
| Carewell Steuart Pharma Private Limited | ₹24.5 Cr (FY 2025) | 79.0% | Tiruvallur, Tamil Nadu, India | |||
| MRHM Pharma Private Limited | ₹24.46 Cr (FY 2024) | 10.0% | Bangalore, Karnataka, India | |||
| Sunberg Life Sciences Private Limitedthis company | ₹24.43 Cr (FY 2025) | -₹11.28 Lakh | -0.5% | 92.0% | 51 | Chennai, Tamil Nadu, India |
| Axon Drugs Private Limited | ₹24.4 Cr (FY 2024) | 4.0% | Chennai, Tamil Nadu, India | |||
| Kemecos India Pvt Ltd | ₹24.35 Cr (FY 2025) | 4.0% | Kolkata, West Bengal, India | |||
| Aeon Formulations Private Limited | ₹24.33 Cr (FY 2025) | -16.0% | Chennai, Tamil Nadu, India |
To see the full peer comparison of Sunberg Life Sciences Private Limited, buy the company report.
Auditor
Sunberg Life Sciences Private Limited is audited by B. Srinivasan & Co. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| B. Srinivasan & Co. | FY 2023 | 004043S |
Shareholding
The shareholding of Sunberg Life Sciences Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Sunberg Life Sciences Private Limited, buy the company report.
Charges & borrowings
Open charges
₹36.52 Cr
Satisfied charges
₹4.57 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 02 Jan 2025 | 101031742 | Hdfc Bank Limited | ₹7 Cr | Open | |
| 26 Aug 2020 | 100370550 | Hdfc Bank Limited | ₹4.02 Cr | Open | |
| 02 Apr 2019 | 100255905 | Hdfc Bank Limited | ₹12.5 Cr | Open | |
| 14 Feb 2018 | 100165671 | Hdfc Bank Limited | ₹13 Cr | Open | |
| 26 Mar 2018 | 100168036 | Dbs Bank Ltd | ₹56.57 Lakh | Satisfied |
To see the full charge records of Sunberg Life Sciences Private Limited, buy the company report.
Total charge records: 6 View all charges
Deals & funding
Sunberg Life Sciences Private Limited has 3 deals on record (2 funding rounds, 1 rights issue), with disclosed funding of ₹7.5 Cr; the latest was in February 2020.
Total deals
3
Funding rounds
2
Rights issue
1
Disclosed funding
₹7.5 Cr
Deals on record (1 of 3)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Feb 2020 | Rights issue | ₹1.9 Cr | Investors: 4 individuals |
To see the full deal history of Sunberg Life Sciences Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving Sunberg Life Sciences Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Sunberg Life Sciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Sunberg Life Sciences Private Limited has a workforce of 51 employees on its EPFO records as of Mar 28, 2024, across 1 active EPFO establishment.
Employee count
51
Active EPFO establishments
1
Employee growth
-17.74%
GST
Sunberg Life Sciences has 2 GST registrations: 2 active.
Total GSTINs
2
Active
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 33AAVCS4160P1ZM | Tamil Nadu | Active | 01 Jul 2017 |
| 34AAVCS4160P1ZK | Puducherry | Active | 22 Feb 2018 |
To see the full GST registrations and return filing status of Sunberg Life Sciences Private Limited, buy the company report.
Recent activity
Sunberg Life Sciences Private Limited has 14 board changes on record since 2015: 6 appointments and 8 cessations. The latest: Alagappan ceased to be Additional Director on 26 Sep 2025.
Ceased
Alagappan ceased to be Additional Director.
Charges
A charge with Hdfc Bank Limited of Rs. 13.00 Cr registered on 14 Feb 2018 with Charge ID 100165671 was modified on 25 Aug 2025.
Charges
A charge with Hdfc Bank Limited of Rs. 7.00 Cr registered on 02 Jan 2025 with Charge ID 101031742 was modified on 15 Apr 2025.
Appointed
Alagappan was appointed as Director.
Ceased
Alagappan Vijayanand ceased to be Director.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 7.00 Cr with Charge ID 101031742 was registered on 02 Jan 2025.
AGM
Sunberg Life Sciences Private Limited last Annual general meeting of members was held on 27 Sep 2024 as per latest MCA records.
Filing
Sunberg Life Sciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chennai.
Charges
A charge with Hdfc Bank Limited of Rs. 4.02 Cr registered on 26 Aug 2020 with Charge ID 100370550 was modified on 30 Jun 2023.
Charges
A charge with Hdfc Bank Limited of Rs. 12.50 Cr registered on 02 Apr 2019 with Charge ID 100255905 was modified on 30 Jun 2023.
Ceased
Ogra Selvanathan Kumaran ceased to be Additional Director.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 4.02 Cr with Charge ID 100370550 was registered on 26 Aug 2020.
17 earlier events are in the company report.
Frequently asked questions
Sunberg Life Sciences is an active private limited company based in Chennai, Tamil Nadu, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 03 February 2015 (11+ years old) and is registered under CIN U51397TN2015PTC099067.
Sunberg Life Sciences has 6 current directors:
- Sivasamy Manohar - Director
- Alagappan - Director
- Sulaiman Abdulhai Mohammed - Director
- Nagappan Kannappan - Director
- Ogra Selvanathan Kumaran - Director
- Vijay Balakumar - Director
The latest financial statements of Sunberg Life Sciences on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 27 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Sunberg Life Sciences is 33AAVCS4160P1ZM, registered in Tamil Nadu. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 34AAVCS4160P1ZK (Puducherry).
The CIN (Corporate Identification Number) of Sunberg Life Sciences is U51397TN2015PTC099067. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sunberg Life Sciences was incorporated on 03 February 2015, making it 11+ years old. It is registered with the Registrar of Companies, Chennai.
Sunberg Life Sciences has 3 deals on record (2 funding rounds, 1 rights issue), with disclosed funding of ₹7.5 Cr; the latest was in February 2020.
The peers of Sunberg Life Sciences by revenue are Pharlink Labs Private Limited, Remidex Pharma Private Limited, Carewell Steuart Pharma Private Limited, MRHM Pharma Private Limited, Axon Drugs Private Limited and 2 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Alagappan ceased to be Additional Director on 26 Sep 2025. Alagappan was appointed as Director on 17 Mar 2025. Alagappan Vijayanand ceased to be Director on 14 Mar 2025. Sunberg Life Sciences has 14 board changes on record in total.
Yes, Sunberg Life Sciences is registered as a medium enterprise under Udyam registration (number: UDYAM-TN-02-0003755).
Sunberg Life Sciences can be reached through the website sun-berg.com. Its registered office is in Chennai, Tamil Nadu, India.